What topical treatments are available for Candida glabrata (a type of fungus) onychomycosis (fungal infection of the nail)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Topical treatments for Candida glabrata onychomycosis include ciclopirox 8% nail lacquer and amorolfine 5% nail lacquer, with ciclopirox being potentially more effective due to Candida glabrata's resistance to azoles. The treatment of Candida glabrata onychomycosis can be challenging due to its resistance to various antifungal agents.

  • Ciclopirox 8% nail lacquer should be applied daily to affected nails for 6-12 months, with nail debridement recommended before application 1.
  • Amorolfine 5% nail lacquer is applied 1-2 times weekly for 6-12 months 1. These treatments work by disrupting fungal cell membranes or inhibiting essential fungal enzymes. However, Candida glabrata often shows resistance to azoles, making ciclopirox potentially more effective. Treatment success is improved by combining topical therapy with mechanical nail debridement or chemical nail avulsion using 40% urea preparations. Complete cure rates with topical treatments alone are modest (20-40%), especially for Candida glabrata infections, which are typically more resistant than other Candida species. For severe or resistant cases, oral antifungals like terbinafine or itraconazole may be necessary in combination with topical therapy 1. Additionally, a study published in 2016 suggested the use of topical 17% flucytosine cream alone or in combination with 3% AmB cream administered daily for 14 days as a third option for C. glabrata infection 1.

From the Research

Topical Treatments for Candida Glabrata Onychomycosis

  • Ciclopirox nail lacquer 8% topical solution has been shown to be effective in the treatment of onychomycosis, including cases caused by Candida species 2
  • Amorolfine 5% and ciclopirox 8% nail lacquers are commonly used in the topical treatment of onychomycosis, and may be used alone or in combination with oral antifungal agents 3
  • Topical monotherapy can be considered for mild to moderate onychomycosis, and is a therapeutic option when oral antifungal agents are contraindicated or cannot be tolerated 4

Mechanism of Action and Efficacy

  • Ciclopirox nail lacquer has a broad spectrum of activity, with efficacy against Candida species and some non-dermatophytes 2
  • Amorolfine and ciclopirox have a different mode of action, but both exhibit a broad antifungal activity 3
  • The use of antifungal nail lacquers in combination with oral agents can improve the efficacy of antifungal therapy 3

Safety and Limitations

  • Ciclopirox nail lacquer is considered extremely safe, with most treatment-emergent adverse effects being transient and localized to the site of action 2
  • Topical antifungal therapies have minimal adverse events, but are less effective than oral antifungal therapies due to poor nail penetration 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.

Journal of the American Academy of Dermatology, 2000

Research

Onychomycosis: An Updated Review.

Recent patents on inflammation & allergy drug discovery, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.